Tuesday, September 16, 2025
HomeIndustriesHealthcare

Healthcare

Adjuvant Opdivo (nivolumab) Continues to Provide Significant, Durable Clinical Benefits for Patients with Radically Resected, High-Risk Muscle-Invasive Urothelial Carcinoma After Three Years in CheckMate...

Bristol Myers Squibb announced three-year follow-up results from the Phase 3 CheckMate -274 trial, demonstrating significant sustained clinical benefits with Opdivo (nivolumab) for the adjuvant...

Breakthrough Discoveries in Human Immunology – Michelson Philanthropies and AAAS/Science Award Transformative Research

Michelson Philanthropies and AAAS/Science award Dr. Aleksandar Obradovic,of the Department of Systems Biology at Columbia University Irving Medical Center, with the 2023 Michelson Philanthropies & Science Prize for Immunology....

Ligand’s Partner Travere Therapeutics Announces FDA Accelerated Approval of FILSPARI™ (sparsentan), the First and Only Non-immunosuppressive Therapy for the Reduction of Proteinuria in IgA...

Ligand Pharmaceuticals Incorporated announced that its partner Travere Therapeutics, Inc.  has received accelerated approval from the U.S. Food and Drug Administration for FILSPARI to...

Emory Healthcare Engages Linus Health on Initiative to Expand Early Detection of Alzheimer’s Disease and Other Dementias

Linus Health, a digital health company focused on transforming brain health, announced that the Goizueta Institute Emory Brain Health and The Seavey Clinic at...

PathAI Announces Two New Executives to Expand Regulatory Expertise and Precision Oncology Commercial Strategy

PathAI, a leading provider of AI-powered pathology tools to advance precision medicine,  announced that Nick Anderson, Ph.D, has joined as Vice President of Regulatory...
0FansLike
0FollowersFollow
spot_img

Hot Topics